Prime Medicine, Inc. (NASDAQ: PRME) reported Q2 EPS of ($0.24), $0.12 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $1.15 million.

For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.